Fig. 11From: The effect of the anti-leukemia inhibitory factor on the immune system in the Balb/c mice bearing breast cancer induced with 4T1 cellsPercentage of regulatory T cells. Anti LIF: mice treated with anti-LIF, Anti LIF & Doxorubicin: mice treated with anti-LIF and doxorubicin, Doxorubicin: mice treated with doxorubicin, control: mice treated with phosphate buffer saline. The data were presented as mean ± SEMBack to article page